EnteroBiotix appoints Elmar Schnee as Executive Chairman
EnteroBiotix Limited (“EBX”), a clinical stage company with the premier platform for full-spectrum microbiome therapeutics, today announced the appointment to its Board of Elmar Schnee as Executive Chairman. Mr. Schnee succeeds Mr. Douglas Thomson, who will continue to serve EBX as a non-executive Board member.
